<?xml version="1.0" encoding="UTF-8"?>
<p>Patients 1, 4, 5, and 6 decreased their L-DOPA equivalent daily dose (LEDD) at year 4 compared with baseline. In patients 3 and 7, 4th year LEDD increased, and in patient 2 remained unchanged compared with baseline (
 <xref rid="table3-0963689718820271" ref-type="table">Table 3</xref>). In the fourth year all patients except patient 1, improved on UPDRS III OFF as compared with the baseline (
 <xref ref-type="fig" rid="fig4-0963689718820271">Fig. 4</xref>) and patients 2, 6, and 7 improved as compared with both baseline and the second year after surgery. Patients 2 and 7, while retaining improvement as compared with the baseline, by the fourth year reversed a certain deterioration observed at the first and second years after surgery.
</p>
